Acer plans to raise $15.7M ahead of Opexa merger

On July 3, rare disease company Acer Therapeutics Inc. (Cambridge, Mass.) said it will raise $15.7 million from a syndicate of new and existing shareholders led by TVM Capital Life Sciences. Acer is ...